| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,480 |
13,758 |
$785K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,508 |
8,197 |
$326K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,496 |
2,119 |
$75K |
| 99215 |
Prolong outpt/office vis |
1,200 |
937 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,111 |
3,042 |
$51K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,168 |
1,687 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,593 |
3,106 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
424 |
357 |
$27K |
| 80305 |
|
3,211 |
2,508 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
288 |
258 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
659 |
549 |
$14K |
| 96160 |
|
1,290 |
989 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
722 |
588 |
$12K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
90 |
76 |
$6K |
| 92552 |
|
420 |
344 |
$6K |
| 90832 |
Psychotherapy, 30 minutes with patient |
154 |
153 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
3,111 |
2,461 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
719 |
590 |
$4K |
| 99173 |
|
837 |
692 |
$4K |
| 96127 |
|
1,141 |
901 |
$3K |
| 81003 |
|
2,076 |
1,600 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
29 |
26 |
$2K |
| 81025 |
|
300 |
241 |
$1K |
| 99384 |
|
13 |
12 |
$1K |
| 85018 |
|
493 |
420 |
$930.01 |
| 92551 |
|
141 |
117 |
$911.56 |
| 99358 |
Prolong nursin fac eval 15m |
32 |
17 |
$833.90 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
494 |
377 |
$824.77 |
| 36416 |
|
345 |
301 |
$561.01 |
| 3079F |
|
2,680 |
2,107 |
$421.09 |
| 3074F |
|
8,604 |
6,935 |
$390.72 |
| 3078F |
|
7,801 |
6,286 |
$390.70 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
870 |
717 |
$330.86 |
| 99408 |
|
59 |
48 |
$327.59 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
20 |
14 |
$264.83 |
| 3077F |
|
878 |
674 |
$200.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
54 |
38 |
$163.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
106 |
80 |
$155.85 |
| 93000 |
|
20 |
12 |
$139.76 |
| 3080F |
|
389 |
308 |
$120.00 |
| 3075F |
|
1,040 |
853 |
$120.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
17 |
14 |
$97.98 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
26 |
22 |
$52.49 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
46 |
32 |
$47.55 |
| 2001F |
|
16,239 |
12,481 |
$0.00 |
| 3008F |
|
17,070 |
13,137 |
$0.00 |
| 2010F |
|
17,350 |
13,328 |
$0.00 |
| 2000F |
|
15,646 |
11,947 |
$0.00 |
| 99000 |
|
3,268 |
2,715 |
$0.00 |
| 3044F |
|
67 |
53 |
$0.00 |
| 2030F |
|
82 |
72 |
$0.00 |
| 4120F |
|
16 |
13 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
26 |
22 |
$0.00 |